OA3-4 LB Elimination of HIV-1 latently infected cells by PKC agonist gnidimacrin alone and in combination with a histone deacetylase inhibitor
Saved in:
Main Authors: | L. Huang (Author), W. Lai (Author), L. Zhu (Author), C.-H. Chen (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2016-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Histone deacetylase inhibitors
by: Marzena Baran, et al.
Published: (2020) -
Clinical Toxicities of Histone Deacetylase Inhibitors
by: Richard L. Piekarz, et al.
Published: (2010) -
Medicinal chemistry of histone deacetylase inhibitors
by: Ružić Dušan, et al.
Published: (2021) -
Zinc binding groups for histone deacetylase inhibitors
by: Lei Zhang, et al.
Published: (2018) -
Role of histone deacetylases and their inhibitors in neurological diseases
by: Li-Ying Zhang, et al.
Published: (2024)